Babson Diagnostics
PrivateLast Round
Strategic
Oct 8, 2024
Total Funding Raised
$44.7M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Babson Diagnostics operates in Healthcare & Life Sciences and is based in Austin, Texas. Its latest recorded funding round was a Strategic round in October 2024.
Babson Diagnostics is a healthcare technology company that provides accurate diagnostic blood testing using small capillary samples collected at retail pharmacy counters and analyzed at CLIA-certified clinical laboratories for quick results.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology
Business Model
B2B2C
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Babson Diagnostics Comparables
Compare Babson Diagnostics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Hims & Hers Health, Inc. | 81% | |
| Tasso | 77% | |
| Chronus Health, Inc. | 75% |
For institutional investors. Book with your work email.
Babson Diagnostics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Strategic | Oct 8, 2024 | ||||
| Series B | Jun 29, 2021 | ||||
| Series A | Sep 24, 2020 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Babson Diagnostics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Prism Venture Partners | Series B, Series A |
| Emerald Development Managers | Strategic, Series B |
| Genesis Merchant Capital | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 27, 2026
Monthly visitors increased 60% MoM, reaching 12.6K.
- May 1, 2025
Web Golinkin appointed President and Chief Commercial Officer.
For institutional investors. Book with your work email.
Babson Diagnostics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Babson Diagnostics's valuation, stock price, and market status.
Is Babson Diagnostics a public or private company?
Babson Diagnostics is a private company.
What is the current stock price of Babson Diagnostics?
Babson Diagnostics is a private company, so its shares have no public market price. Caplight tracks Babson Diagnostics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Babson Diagnostics worth (valuation)?
Valuation information for Babson Diagnostics is not publicly available.
Can I buy Babson Diagnostics stock?
Babson Diagnostics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Babson Diagnostics's last funding round?
Babson Diagnostics's most recent funding round was Strategic on October 8, 2024.
Who are the main investors in Babson Diagnostics?
Key investors in Babson Diagnostics include Prism Venture Partners, Emerald Development Managers, Genesis Merchant Capital.
Will Babson Diagnostics IPO soon?
No public IPO plans have been announced for Babson Diagnostics.
How can I track Babson Diagnostics secondary market activity?
Caplight tracks bids, offers, and trades in Babson Diagnostics's shares on secondary markets.